Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000903423-17-000632
Filing Date
2017-11-07
Accepted
2017-11-07 19:42:39
Documents
1
Period of Report
2017-11-06

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT glaxo-spero.html 4  
1 OWNERSHIP DOCUMENT glaxo-spero.xml 4 19851
  Complete submission text file 0000903423-17-000632.txt   21592
Mailing Address 980 GREAT WEST ROAD BRENTFORD MIDDLESEX X0 TW8 9GS
Business Address 980 GREAT WEST ROAD BRENTFORD MIDDLESEX X0 TW8 9GS 011442080475000
GLAXOSMITHKLINE PLC (Reporting) CIK: 0001131399 (see all company filings)

State of Incorp.: X0
Type: 4 | Act: 34 | File No.: 001-38266 | Film No.: 171184798
SIC: 2834 Pharmaceutical Preparations

Mailing Address 675 MASSACHUSETTS AVENUE 14TH FLOOR CAMBRIDGE MA 02139
Business Address 675 MASSACHUSETTS AVENUE 14TH FLOOR CAMBRIDGE MA 02139 857-242-1600
Spero Therapeutics, Inc. (Issuer) CIK: 0001701108 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations